Gilead and Global Fund Expand HIV Prevention Access
Gilead will supply lenacapavir at no profit to up to two million people in high-incidence, low-income countries through a partnership with the Global Fund.
Gilead will supply lenacapavir at no profit to up to two million people in high-incidence, low-income countries through a partnership with the Global Fund.
Precisis strengthens its leadership team with Steven Griffiths as VP European Sales to drive international growth and expand its presence in key markets.
On August 30 and 31, 2025, APOTHEKENTOUR comes to Leipzig – bringing knowledge, innovations, and top industry players directly to the region.
On July 1st, the first Pharma Day by the Air Cargo Community Frankfurt took off with over 150 participants and offered inspiring insights into the dynamic world of pharmaceutical logistics.
Prof. Magdalena Götz has received the Future Insight Prize 2025. Her research on converting glial cells into neurons opens up groundbreaking therapeutic possibilities.
Bayer welcomes the U.S. Supreme Court’s decision to involve the Solicitor General in the Durnell case – a potential turning point in the glyphosate litigation.
Araris Biotech has been awarded the Strüngmann Award 2025 for its groundbreaking ADC technology – a milestone for targeted cancer therapies.
Max Zeller Söhne AG draws attention to zeller entspannung with a bold campaign centered around rare phobias. The herbal remedy is repositioned as a solution for stress and anxiety.
Torrent Pharma acquires a majority stake in JB Chemicals & Pharmaceuticals from KKR for over INR 25,000 crore and announces a subsequent merger. The deal significantly strengthens Torrent’s market presence in India and globally.
Procter & Gamble launches the campaign “Where Quality Lives” together with Kai Pflaume – a tribute to local production, innovation, and consumer trust in Germany.